Profile data is unavailable for this security.
About the company
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
- Revenue in USD (TTM)8.71bn
- Net income in USD2.48bn
- Incorporated1995
- Employees15.64k
- LocationIntuitive Surgical Inc1020 Kifer RoadSUNNYVALE 94086United StatesUSA
- Phone+1 (408) 523-2100
- Fax+1 (408) 523-1390
- Websitehttps://www.intuitive.com/en-us/about-us/company
More ▼
Mergers & acquisitions
| Acquired company | ISRG:NSQ since announced | Transaction value |
|---|---|---|
| Ab Medica Spa-Da Vinci & Ion Distribution Business | -13.60% | -- |
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Inc | 5.02bn | 1.31bn | 37.84bn | 9.98k | 28.98 | 6.82 | 24.88 | 7.54 | 8.91 | 8.91 | 34.05 | 37.83 | 0.6983 | 2.45 | 5.65 | 503,159.20 | 18.26 | 14.24 | 20.73 | 16.53 | 58.76 | 56.85 | 26.15 | 20.35 | 2.49 | 58.86 | 0.1082 | 32.62 | 10.95 | 12.44 | 13.75 | 19.98 | 8.23 | 5.89 |
| IDEXX Laboratories Inc | 3.93bn | 894.97m | 43.52bn | 11.00k | 50.00 | 30.17 | 42.29 | 11.07 | 10.82 | 10.82 | 47.53 | 17.93 | 1.20 | 3.87 | 6.81 | 357,439.60 | 27.26 | 28.11 | 40.01 | 42.15 | 61.28 | 59.56 | 22.76 | 22.19 | 0.8111 | 53.37 | 0.3937 | 0.00 | 6.46 | 10.12 | 5.07 | 15.73 | -3.35 | -- |
| Veeva Systems Inc | 2.86bn | 780.66m | 46.02bn | 7.29k | 59.75 | 7.39 | 56.03 | 16.12 | 4.71 | 4.71 | 17.25 | 38.11 | 0.4093 | -- | 6.06 | 391,622.10 | 11.19 | 11.33 | 13.85 | 14.35 | 75.50 | 72.60 | 27.34 | 23.96 | -- | -- | 0.00 | 0.00 | 16.20 | 19.99 | 35.84 | 18.85 | 36.56 | -- |
| Edwards Lifesciences Corp | 5.54bn | 1.44bn | 46.22bn | 15.80k | 32.51 | 4.56 | 29.29 | 8.35 | 2.42 | 7.00 | 9.31 | 17.28 | 0.4867 | 0.984 | 7.45 | 350,557.00 | 12.63 | 14.52 | 14.28 | 16.61 | 79.38 | 79.01 | 25.95 | 25.54 | 3.66 | -- | 0.0554 | 0.00 | 8.57 | 4.58 | 14.55 | 5.94 | 0.2857 | -- |
| Becton Dickinson and Co | 20.87bn | 1.50bn | 50.87bn | 74.00k | 34.37 | 2.02 | 13.16 | 2.44 | 5.16 | 5.16 | 71.96 | 88.07 | 0.3842 | 3.32 | 7.47 | 281,986.50 | 2.76 | 2.55 | 3.20 | 2.92 | 44.68 | 45.30 | 7.18 | 7.29 | 0.6427 | 7.18 | 0.4329 | 76.93 | 4.16 | 3.14 | 15.99 | 10.56 | -5.40 | 4.29 |
| Cencora Inc | 310.23bn | 1.69bn | 57.63bn | 42.00k | 34.51 | 56.89 | 20.49 | 0.1858 | 8.62 | 8.62 | 1,574.00 | 5.23 | 4.59 | 16.40 | 12.70 | 7,386,481.00 | 2.53 | 1.12 | 10.78 | 4.84 | 3.29 | 3.24 | 0.55 | 0.2556 | 0.517 | 17.30 | 0.8694 | 62.15 | 12.12 | 10.36 | -13.53 | 13.02 | 9.45 | 4.98 |
| Medtronic PLC | 33.54bn | 4.66bn | 114.55bn | 95.00k | 24.72 | 2.39 | 15.17 | 3.42 | 3.62 | 3.62 | 26.01 | 37.46 | 0.3692 | 2.17 | 5.31 | 353,021.10 | 5.16 | 4.55 | 5.95 | 5.15 | 65.39 | 66.25 | 13.99 | 13.07 | 1.42 | 11.19 | 0.3714 | 84.20 | 3.62 | 3.01 | 26.82 | -0.2723 | 8.91 | 5.33 |
| Danaher Corp | 23.82bn | 3.77bn | 147.08bn | 61.00k | 39.85 | 2.89 | 24.02 | 6.17 | 5.16 | 5.16 | 32.62 | 71.06 | 0.2931 | 3.70 | 6.92 | 390,491.80 | 4.63 | 5.91 | 5.09 | 6.54 | 59.80 | 59.40 | 15.81 | 19.38 | 1.05 | 15.55 | 0.2447 | 14.68 | -0.0628 | 5.92 | -7.17 | 10.53 | 16.98 | 9.40 |
| Stryker Corp | 23.22bn | 2.86bn | 150.87bn | 53.00k | 53.28 | 7.21 | 38.48 | 6.50 | 7.41 | 7.41 | 60.17 | 54.78 | 0.5437 | 1.62 | 6.25 | 438,075.50 | 6.69 | 6.64 | 8.11 | 7.94 | 64.57 | 63.83 | 12.31 | 13.02 | 0.9985 | -- | 0.445 | 44.01 | 10.23 | 8.71 | -5.43 | 7.52 | 3.07 | 9.27 |
| Boston Scientific Corp | 17.55bn | 2.03bn | 153.66bn | 53.00k | 76.13 | 6.92 | 46.34 | 8.75 | 1.36 | 1.36 | 11.79 | 15.02 | 0.4571 | 2.02 | 7.03 | 331,188.70 | 5.27 | 3.08 | 6.10 | 3.57 | 68.73 | 68.51 | 11.54 | 7.78 | 0.8834 | 9.84 | 0.335 | 0.00 | 17.61 | 9.30 | 18.03 | 25.38 | 5.31 | -- |
| Thermo Fisher Scientific Inc | 42.90bn | 6.52bn | 162.60bn | 125.00k | 25.28 | 3.29 | 16.98 | 3.79 | 17.04 | 17.04 | 112.23 | 130.84 | 0.4374 | 4.86 | 4.47 | 343,184.00 | 6.73 | 7.68 | 7.81 | 9.02 | 41.34 | 44.24 | 15.38 | 16.64 | 1.38 | 24.80 | 0.4086 | 7.09 | 0.0513 | 10.92 | 5.67 | 11.33 | 8.62 | 15.48 |
| Intuitive Surgical Inc | 8.71bn | 2.48bn | 188.55bn | 15.64k | 77.16 | 11.02 | 62.32 | 21.63 | 6.82 | 6.82 | 24.01 | 47.73 | 0.4973 | 2.01 | 7.42 | 557,289.90 | 14.23 | 12.31 | 15.61 | 13.71 | 67.09 | 67.30 | 28.62 | 26.11 | 3.97 | -- | 0.00 | 0.00 | 17.24 | 13.27 | 29.18 | 10.98 | 21.16 | -- |
| Abbott Laboratories | 42.34bn | 13.50bn | 232.44bn | 114.00k | 17.27 | 4.76 | 13.94 | 5.49 | 7.74 | 7.74 | 24.23 | 28.05 | 0.5502 | 2.76 | 6.08 | 371,438.60 | 17.54 | 10.17 | 21.36 | 12.46 | 56.06 | 56.19 | 31.89 | 18.50 | 1.27 | 43.72 | 0.2125 | 44.79 | 4.59 | 5.63 | 134.18 | 30.06 | 6.14 | 11.44 |
Data as of Jul 11 2025. Currency figures normalised to Intuitive Surgical Inc's reporting currency: US Dollar USD
32.86%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 30.98m | 8.69% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 18.92m | 5.31% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 15.37m | 4.31% |
| T. Rowe Price Associates, Inc. (IM)as of 31 Mar 2025 | 13.26m | 3.72% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2025 | 8.69m | 2.44% |
| Geode Capital Management LLCas of 31 Mar 2025 | 8.08m | 2.27% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2025 | 7.52m | 2.11% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2025 | 5.54m | 1.55% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 4.60m | 1.29% |
| AllianceBernstein LPas of 31 Mar 2025 | 4.22m | 1.18% |
More ▼
Data from 31 Dec 2024 - 31 Mar 2025Source: FactSet Research Systems Inc.
